Caporali, R., Ravasio, R., Raimondo, P., & Salaffi, F. (2021). Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy. Global and Regional Health Technology Assessment, 8(1), 69–79. https://doi.org/10.33393/grhta.2021.2267